Indonesia's Agency for Food and Drug Control (BPOM) Holds Workshop on Vaccine Quality Management

Jun 16, 2013 19:00 JST

Source: PT Bio Farma (Persero)

Bandung, W Java, Indonesia, Jun 16, 2013 - (ACN Newswire) - Indonesia's Agency for Food and Drug Control (BPOM) is to hold a workshop on the quality management for vaccine making of which it has good experience to share with member states of the Organization of Islamic Conference (OIC).

The workshop is to be held on 17 June 2013 alongside the on-going 2nd meeting of vaccine- and medicine-manufacturers of OIC member states in the city of Bandung, West Java province. Delegates and experts from nine countries that already have their vaccine making facilities out of the total 57 OIC member countries are attending the meeting which runs from 16 to 19 June, 2013.

The BPOM workshop is aimed sharing Indonesian experience with other OIC member states on strengthening National Regulation Authority (NRA)'s function in vaccine manufacturing for global markets. NRAs are national regulatory agencies responsible for ensuring that products released for public distribution (normally pharmaceuticals and biological products, such as vaccines) are evaluated properly and meet international standards of quality and safety.

Countries producing vaccines need to exercise six critical control functions, and exercise them in a competent and independent manner, backed up with enforcement power. The six functions are a published set of requirements for licensing, surveillance of vaccine field performance, system of lot release, use of laboratory when needed, regular inspections for good manufacturing practices (GMP) and clinical performance evaluation.

The workshop will start with keynote remarks by BPOM head Lucky S. Slamet, said workshop organizers. Bio Farma will take part in the workshop and share the experiences that the 123-year old vaccine making company has, organizers said.

Bio Farma Sales & Marketing Director Dr. Mahendra Suhardono is scheduled to speak on quality management system (Manufacture, Pre Qualification of Vaccine) in a way to meeting the GMP as set out by the WHO for its prequalification so that the vaccine products are exportable.

Dr. Suhardono is expected to speak about how Bio Farma has been able to maintain an integrated system of quality control management and efforts on keeping it update with latest GMP requirements. Bio Farma is Indonesia's only vaccine manufacturer whose products have been recognized by WHO since 1997, so that the company can supply its products to over 120 countries worldwide.

Currently the needs for Expanded Program on Immunization (EPI) vaccines in Indonesia have been supplied solely by Bio Farma by producing and distributing over 1.7 billion doses of vaccine per year to meet the needs of EPI vaccine for national immunization program.

Bio Farma has an outstanding international reputation based on the WHO prequalification for all of its EPI vaccine products, and has also implemented green industry and is environmently friendly. WHO acknowledges that Bio Farma vaccine products are of high quality, efficacious, and affordable.

Bio Farma products are through the direct distribution or through various agencies such as UNICEF and PAHO. The company has obtained the Best Export Performance from the Indonesian Trade Ministry consecutively in 2010,2011, 2012 as evidence of its consistent exceptional performance.

Contact:

M. Rahman Rustan  
Corporate Secretary 
Bio Farma 
+62 22 2033755
+62 22 2041306
pr@biofarma.co.id

Source: PT Bio Farma (Persero)
Sectors: BioTech

Latest Release

Honda Opens New R&D Facility in Bengaluru to Accelerate Electrification in India
May 09, 2024 14:13 JST

Fujitsu introduces "explainable AI" for use in genomic medicine and cancer treatment planning
May 09, 2024 10:41 JST

Mitsubishi Heavy Industries Increases Dividends on Back of Historically High FY2023 Results, Releases FY2024 Guidance
May 08, 2024 14:27 JST

Rome becomes the first European city to offer open loop transit payments to JCB Cardmembers
May 08, 2024 12:00 JST

NEC X Invests in Public Safety Startup Multitude Insights, Scaling AI-Powered Collaboration and Information Sharing for Law Enforcement
May 08, 2024 10:24 JST

ServiceNow and Fujitsu announce strategic commitment to launch innovative cross-industry solutions
May 08, 2024 08:52 JST

Fujitsu launches mainframe modernization automation service for the Japanese market
May 07, 2024 17:53 JST

MHI Agrees to Collaborate with Chiyoda Corporation for Licensing of CO2 Capture Technologies
May 07, 2024 13:49 JST

Four-strong TOYOTA GAZOO Racing squad to push for more Portugal success
May 02, 2024 18:05 JST

Spectacular Spa awaits TOYOTA GAZOO Racing
May 02, 2024 17:46 JST

Q&M Dental Enhances Digital Capabilities by Integrating Align Technology's Newest iTero Lumina(TM) Intraoral Scanner Across Dental Clinics in Singapore
May 02, 2024 11:00 JST

Sumitomo Metal Mining and Mitsubishi Corporation to Participate in Kalgoorlie Nickel Project - Goongarrie Hub
Apr 30, 2024 19:08 JST

New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg
Apr 30, 2024 18:00 JST

SPARX Group Establishes Space Frontiers Second Fund
Apr 29, 2024 18:49 JST

MHI Establishes Local Subsidiary "Mitsubishi Heavy Industries Vietnam"
Apr 29, 2024 18:00 JST

POSCO Future M and Honda Reach Basic Agreement on Collaboration for Production of Cathode Materials for Automotive Batteries in Canada
Apr 29, 2024 14:25 JST

Honda Plans to Establish Comprehensive Electric Vehicle Value Chain in Ontario, Canada
Apr 29, 2024 14:16 JST

JCB enables JCB Contactless acceptance at Taichung MRT in Taiwan
Apr 26, 2024 10:00 JST

Mazda Production and Sales Results for March 2024 and for April 2023 through March 2024
Apr 25, 2024 18:21 JST

MHI Begins Operation of SOEC Test Module the Next-Generation High-Efficiency Hydrogen Production Technology at Takasago Hydrogen Park
Apr 25, 2024 17:45 JST

More Latest Release >>

Latest Release

Related Release